| CSPAX | GLNLX | CSPAX / GLNLX | |
| Total Expense Ratio | 1.04 | 1.35 | 77% |
| Annual Report Gross Expense Ratio | 1.04 | 1.76 | 59% |
| Fund Existence | 25 years | 15 years | - |
| Gain YTD | 14.567 | 10.252 | 142% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 89B | 67.5M | 131,852% |
| Annual Yield % from dividends | 0.60 | 0.36 | 168% |
| Returns for 1 year | 15.10 | 6.50 | 232% |
| Returns for 3 years | 40.37 | 29.54 | 137% |
| Returns for 5 years | -2.97 | -3.09 | 96% |
| Returns for 10 years | 82.19 | 63.74 | 129% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TREMX | 9.99 | 0.14 | +1.42% |
| T. Rowe Price Emerging Europe | |||
| GATMX | 19.37 | 0.22 | +1.15% |
| Goldman Sachs International T/M Eq A | |||
| MCSSX | 38.89 | 0.30 | +0.78% |
| NYLI WMC Enduring Capital Investor Class | |||
| TSMUX | 19.56 | 0.15 | +0.77% |
| Nuveen Quant Small/Mid Cap Eq W | |||
| ACSHX | 35.10 | 0.20 | +0.57% |
| Invesco Comstock R5 | |||